Article
Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience.
Journal of gastroenterology and hepatology - 1 Feb 2008
Sood Ajit, Midha Vandana, Hissar Syed, Kumar Manoj, Suneetha Pothakamuri V, Bansal Manu, Sood Nina, Sakhuja Puja, Sarin Shiv K
Abstract excerpt
BACKGROUND AND AIMS: In chronic hepatitis C virus (HCV) infection with genotype 3, therapy with pegylated interferon (peg-IFN) alfa-2b in a dose of 1.5 mug/kg/week and ribavirin (800-1000 mg/day) is recommended for 24 weeks. Reduced doses of peg-IFN may increase compliance and decrease cost and adverse events. This study aimed to assess the safety and efficacy of two different regimens of peg-IFN alfa-2b, in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.